KORU MEDICAL SYSTEMS, INC.: 10-Q filed 2014-07-15
What KORU MEDICAL SYSTEMS, INC. reported in its quarterly report filed 2014-07-15 (fiscal Q1 2015): 34 published measures, 68 facts as tagged in accession 0001161697-14-000329.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2014-07-15
- Fiscal period
- fiscal Q1 2015
- Accession
- 0001161697-14-000329 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All KORU MEDICAL SYSTEMS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-05-31 | 6,671,325 | USD | |
| At 2014-02-28 | 6,208,708 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-05-31 | 1,288,524 | USD | |
| At 2014-02-28 | 1,016,838 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-05-31 | 5,382,801 | USD | |
| At 2014-02-28 | 5,191,870 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-05-31 | 2,338,748 | USD | |
| At 2014-02-28 | 2,227,398 | USD | |
| At 2013-05-31 | 1,633,274 | USD | |
| At 2013-02-28 | 1,930,321 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-01 to 2014-05-31 | 158,056 | USD | 92 |
| 2013-03-01 to 2013-05-31 | 73,354 | USD | 92 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-01 to 2014-05-31 | 265,690 | USD | 92 |
| 2013-03-01 to 2013-05-31 | 214,421 | USD | 92 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-01 to 2014-05-31 | 91,427 | USD | 92 |
| 2013-03-01 to 2013-05-31 | 68,232 | USD | 92 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-03-01 to 2013-05-31 | -439,306 | USD | 92 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-01 to 2014-05-31 | -154,340 | USD | 92 |
| 2013-03-01 to 2013-05-31 | -72,162 | USD | 92 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-05-31 | 1,642,015 | USD | |
| At 2014-02-28 | 1,483,959 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-01 to 2014-05-31 | 37,081,667 | shares | 92 |
| 2013-03-01 to 2013-05-31 | 36,661,667 | shares | 92 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-01 to 2014-05-31 | 37,081,667 | shares | 92 |
| 2013-03-01 to 2013-05-31 | 36,661,667 | shares | 92 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-01 to 2014-05-31 | 86,096 | USD | 92 |
| 2013-03-01 to 2013-05-31 | 38,287 | USD | 92 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-05-31 | 871,691 | USD | |
| At 2014-02-28 | 839,059 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-01 to 2014-05-31 | 32,875 | USD | 92 |
| 2013-03-01 to 2013-05-31 | 41,175 | USD | 92 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-01 to 2014-05-31 | 241,099 | USD | 92 |
| 2013-03-01 to 2013-05-31 | 125,099 | USD | 92 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-05-31 | 5,663,258 | USD | |
| At 2014-02-28 | 5,295,291 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-03-01 to 2013-05-31 | 4,447 | USD | 92 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-05-31 | 1,049,208 | USD | |
| At 2014-02-28 | 771,902 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-05-31 | 520,312 | USD | |
| At 2014-02-28 | 246,622 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-05-31 | 1,654,370 | USD | |
| At 2014-02-28 | 1,744,813 | USD |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-05-31 | 1,024,585 | USD | |
| At 2014-02-28 | 818,723 | USD |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-01 to 2014-05-31 | 1,094,065 | USD | 92 |
| 2013-03-01 to 2013-05-31 | 951,159 | USD | 92 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-01 to 2014-05-31 | 131,396 | USD | 92 |
| 2013-03-01 to 2013-05-31 | 37,754 | USD | 92 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-05-31 | 37,081,667 | shares | |
| At 2014-02-28 | 36,661,667 | shares |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-05-31 | 105,323 | USD | |
| At 2014-02-28 | 43,305 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-05-31 | 136,376 | USD | |
| At 2014-02-28 | 74,358 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-05-31 | 318,916 | USD | |
| At 2014-02-28 | 263,465 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-01 to 2014-05-31 | 244,152 | USD | 92 |
| 2013-03-01 to 2013-05-31 | 111,641 | USD | 92 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-01 to 2014-05-31 | 59,690 | USD | 92 |
| 2013-03-01 to 2013-05-31 | 54,937 | USD | 92 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-01 to 2014-05-31 | 3,053 | USD | 92 |
| 2013-03-01 to 2013-05-31 | -13,458 | USD | 92 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-01 to 2014-05-31 | -90,443 | USD | 92 |
| 2013-03-01 to 2013-05-31 | -171,076 | USD | 92 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-01 to 2014-05-31 | 205,862 | USD | 92 |
| 2013-03-01 to 2013-05-31 | 112,658 | USD | 92 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-01 to 2014-05-31 | 273,690 | USD | 92 |
| 2013-03-01 to 2013-05-31 | 86,450 | USD | 92 |
Inspect the source
- Entity
- KORU MEDICAL SYSTEMS, INC. / CIK 0000704440
- Captured
- 2026-09-19T14:58:00.731Z
- SEC response SHA-256
b53967f6fe0da17327c3bbc894c28ecf420f6c43e7707a871a63a9c303887166
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000704440.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))